274 related articles for article (PubMed ID: 27376534)
41. Structural features distinguishing infectious ex vivo mammalian prions from non-infectious fibrillar assemblies generated in vitro.
Terry C; Harniman RL; Sells J; Wenborn A; Joiner S; Saibil HR; Miles MJ; Collinge J; Wadsworth JDF
Sci Rep; 2019 Jan; 9(1):376. PubMed ID: 30675000
[TBL] [Abstract][Full Text] [Related]
42. De novo generation of infectious prions in vitro produces a new disease phenotype.
Barria MA; Mukherjee A; Gonzalez-Romero D; Morales R; Soto C
PLoS Pathog; 2009 May; 5(5):e1000421. PubMed ID: 19436715
[TBL] [Abstract][Full Text] [Related]
43. Pathology of SSLOW, a transmissible and fatal synthetic prion protein disorder, and comparison with naturally occurring classical transmissible spongiform encephalopathies.
Jeffrey M; McGovern G; Makarava N; González L; Kim YS; Rohwer RG; Baskakov IV
Neuropathol Appl Neurobiol; 2014 Apr; 40(3):296-310. PubMed ID: 23578208
[TBL] [Abstract][Full Text] [Related]
44. Two alternative pathways for generating transmissible prion disease de novo.
Makarava N; Savtchenko R; Baskakov IV
Acta Neuropathol Commun; 2015 Nov; 3():69. PubMed ID: 26556038
[TBL] [Abstract][Full Text] [Related]
45. Ex vivo mammalian prions are formed of paired double helical prion protein fibrils.
Terry C; Wenborn A; Gros N; Sells J; Joiner S; Hosszu LL; Tattum MH; Panico S; Clare DK; Collinge J; Saibil HR; Wadsworth JD
Open Biol; 2016 May; 6(5):. PubMed ID: 27249641
[TBL] [Abstract][Full Text] [Related]
46. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
[TBL] [Abstract][Full Text] [Related]
47. Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease.
Galeno R; Di Bari MA; Nonno R; Cardone F; Sbriccoli M; Graziano S; Ingrosso L; Fiorini M; Valanzano A; Pasini G; Poleggi A; Vinci R; Ladogana A; Puopolo M; Monaco S; Agrimi U; Zanusso G; Pocchiari M
J Virol; 2017 Jun; 91(11):. PubMed ID: 28298604
[TBL] [Abstract][Full Text] [Related]
48. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
Ritchie DL; Barria MA
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845
[TBL] [Abstract][Full Text] [Related]
49. In situ formation of protease-resistant prion protein in transmissible spongiform encephalopathy-infected brain slices.
Bessen RA; Raymond GJ; Caughey B
J Biol Chem; 1997 Jun; 272(24):15227-31. PubMed ID: 9182546
[TBL] [Abstract][Full Text] [Related]
50. Natural and synthetic prion structure from X-ray fiber diffraction.
Wille H; Bian W; McDonald M; Kendall A; Colby DW; Bloch L; Ollesch J; Borovinskiy AL; Cohen FE; Prusiner SB; Stubbs G
Proc Natl Acad Sci U S A; 2009 Oct; 106(40):16990-5. PubMed ID: 19805070
[TBL] [Abstract][Full Text] [Related]
51. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates.
Soto C; Estrada L; Castilla J
Trends Biochem Sci; 2006 Mar; 31(3):150-5. PubMed ID: 16473510
[TBL] [Abstract][Full Text] [Related]
52. Beta-sheet core of human prion protein amyloid fibrils as determined by hydrogen/deuterium exchange.
Lu X; Wintrode PL; Surewicz WK
Proc Natl Acad Sci U S A; 2007 Jan; 104(5):1510-5. PubMed ID: 17242357
[TBL] [Abstract][Full Text] [Related]
53. The engineered peptide construct NCAM1-Aβ inhibits fibrillization of the human prion protein (PrP).
Gielnik M; Zhukova L; Zhukov I; Gräslund A; Kozak M; Wärmländer S
Acta Biochim Pol; 2022 Feb; 69(1):257-261. PubMed ID: 35143147
[TBL] [Abstract][Full Text] [Related]
54. Nucleic acid and prion protein interaction produces spherical amyloids which can function in vivo as coats of spongiform encephalopathy agent.
Nandi PK; Nicole JC
J Mol Biol; 2004 Nov; 344(3):827-37. PubMed ID: 15533448
[TBL] [Abstract][Full Text] [Related]
55. A new mechanism for transmissible prion diseases.
Makarava N; Kovacs GG; Savtchenko R; Alexeeva I; Ostapchenko VG; Budka H; Rohwer RG; Baskakov IV
J Neurosci; 2012 May; 32(21):7345-55. PubMed ID: 22623680
[TBL] [Abstract][Full Text] [Related]
56. Overexpression of chimaeric murine/ovine PrP (A136H154Q171) in transgenic mice facilitates transmission and differentiation of ruminant prions.
Griffiths PC; Plater JM; Chave A; Jayasena D; Tout AC; Rice PB; Vickery CM; Spiropoulos J; Stack MJ; Windl O
J Gen Virol; 2013 Nov; 94(Pt 11):2577-2586. PubMed ID: 23761404
[TBL] [Abstract][Full Text] [Related]
57. Conformational stability of mammalian prion protein amyloid fibrils is dictated by a packing polymorphism within the core region.
Cobb NJ; Apostol MI; Chen S; Smirnovas V; Surewicz WK
J Biol Chem; 2014 Jan; 289(5):2643-50. PubMed ID: 24338015
[TBL] [Abstract][Full Text] [Related]
58. Prion protein transgenes and the neuropathology in prion diseases.
DeArmond SJ; Prusiner SB
Brain Pathol; 1995 Jan; 5(1):77-89. PubMed ID: 7767493
[TBL] [Abstract][Full Text] [Related]
59. A new model for sensitive detection of zoonotic prions by PrP transgenic Drosophila.
Thackray AM; Andréoletti O; Spiropoulos J; Bujdoso R
J Biol Chem; 2021 Aug; 297(2):100878. PubMed ID: 34270959
[TBL] [Abstract][Full Text] [Related]
60. Glycosylphosphatidylinositol anchor-dependent stimulation pathway required for generation of baculovirus-derived recombinant scrapie prion protein.
Imamura M; Kato N; Yoshioka M; Okada H; Iwamaru Y; Shimizu Y; Mohri S; Yokoyama T; Murayama Y
J Virol; 2011 Mar; 85(6):2582-8. PubMed ID: 21228241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
